KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Receivables (2016 - 2025)

Historic Receivables for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $115.6 million.

  • Opko Health's Receivables fell 1262.27% to $115.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.6 million, marking a year-over-year decrease of 1262.27%. This contributed to the annual value of $143.0 million for FY2024, which is 1408.13% up from last year.
  • As of Q3 2025, Opko Health's Receivables stood at $115.6 million, which was down 1262.27% from $125.4 million recorded in Q2 2025.
  • Over the past 5 years, Opko Health's Receivables peaked at $320.5 million during Q1 2021, and registered a low of $107.3 million during Q2 2024.
  • Over the past 5 years, Opko Health's median Receivables value was $131.5 million (recorded in 2022), while the average stood at $167.3 million.
  • In the last 5 years, Opko Health's Receivables skyrocketed by 13875.34% in 2021 and then crashed by 5172.73% in 2022.
  • Opko Health's Receivables (Quarter) stood at $261.5 million in 2021, then crashed by 49.72% to $131.5 million in 2022, then decreased by 4.64% to $125.4 million in 2023, then increased by 14.08% to $143.0 million in 2024, then fell by 19.16% to $115.6 million in 2025.
  • Its Receivables stands at $115.6 million for Q3 2025, versus $125.4 million for Q2 2025 and $121.9 million for Q1 2025.